These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 8430921

  • 1. Behavioral and cognitive effect of theophylline: a dose-response study.
    Stein MA, Lerner CA.
    Ann Allergy; 1993 Feb; 70(2):135-40. PubMed ID: 8430921
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Behavior abnormalities and poor school performance due to oral theophylline use.
    Rachelefsky GS, Wo J, Adelson J, Mickey MR, Spector SL, Katz RM, Siegel SC, Rohr AS.
    Pediatrics; 1986 Dec; 78(6):1133-8. PubMed ID: 3786037
    [Abstract] [Full Text] [Related]

  • 7. Improved behavior and sleep after adenotonsillectomy in children with sleep-disordered breathing.
    Wei JL, Mayo MS, Smith HJ, Reese M, Weatherly RA.
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):974-9. PubMed ID: 17938319
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, Scherer N, SPD503 Study Group.
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sequential evaluation of behavioral treatments and methylphenidate dosage for children with attention deficit hyperactivity disorder.
    Gulley V, Northup J, Hupp S, Spera S, LeVelle J, Ridgway A.
    J Appl Behav Anal; 2003 Jan; 36(3):375-8. PubMed ID: 14596580
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
    Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC.
    J Pediatr; 2001 Aug; 139(2):189-96. PubMed ID: 11487742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iron and zinc supplementation does not improve parent or teacher ratings of behavior in first grade Mexican children exposed to lead.
    Kordas K, Stoltzfus RJ, López P, Rico JA, Rosado JL.
    J Pediatr; 2005 Nov; 147(5):632-9. PubMed ID: 16291354
    [Abstract] [Full Text] [Related]

  • 17. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
    Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S, Reddick WE.
    J Clin Oncol; 2004 Dec 01; 22(23):4795-803. PubMed ID: 15570081
    [Abstract] [Full Text] [Related]

  • 18. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine.
    Stein MA, Krasowski M, Leventhal BL, Phillips W, Bender BG.
    Arch Pediatr Adolesc Med; 1996 Mar 01; 150(3):284-8. PubMed ID: 8603222
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI, Hong SD, Kim SY, Kim EJ, Kim JH, Kim JH, Park MK, Park S, Park JH, Oh EY, Lim TS, Cheong S, Cho IH, Choi JW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):210-6. PubMed ID: 17046131
    [Abstract] [Full Text] [Related]

  • 20. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder.
    Bilici M, Yildirim F, Kandil S, Bekaroğlu M, Yildirmiş S, Değer O, Ulgen M, Yildiran A, Aksu H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan 30; 28(1):181-90. PubMed ID: 14687872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.